OR4K11P

Across TCGA pan-cancer cohorts, OR4K11P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR4K11P data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher OR4K11P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR4K11P expression acts as an unfavorable survival marker, although some lineages such as BRCA show a favorable association.

KIRC, ESCA, and STAD are the cancer types where OR4K11P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.217	0.800	<.001	54	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
STAD	OS	Tertile	IV	0.074	0.540	.024	27	view →
READ	OS	Tertile	All	0.069	0.910	<.001	27	view →
COAD	DFS	Tertile	All	0.235	0.790	.010	24	view →
UCEC	OS	Tertile	All	0.725	0.877	.016	18	view →
PCPG	OS	Tertile	All	0.670	0.945	.008	15	view →
BRCA	OS	Quartile	II,III,IV	0.977	0.952	.022	10	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR4K11P–KIRC (DFS)

Open the KIRC breakdown →